Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR vaccine immunogenicity in pediatric patients receiving low-dose corticosteroids
jRCTs031190014Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Measles and Rubella Vaccine (PT Bio Farma) in measles and rubella, sponsored by Japan Society for the Promotion of Science. Primary endpoint: Positive seroconversion rate of specific virus antibody after vaccination. Started May 2019; status: completed.
02
Drugs
Measles and Rubella Vaccine (PT Bio Farma)
03
Conditions
measlesrubella
Beyond the preview
Go deeper on jRCTs031190014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190014.